The company has withdrawn its appeal in the lawsuit filed by Ranbaxy against the US health regulator challenging FDA’s decision to revoke approvals for generic versions of Nexium and Valcyte.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
